Publication:
Efficacy and safety of liraglutide vs placebo in children and adolescents with type 2 diabetes: the ellipse randomised trial results

dc.contributor.authorsBarrett, T.; Tamborlane, W. V.; Fainberg, U.; Frimer-Larsen, H.; Hafez, M.; Hale, P. M.; Jalaludin, M. Y.; Kovarenko, M.; Libman, I.; Rao, P. V.; Shehadeh, N.; Turan, S.; Weghuber, D.; Barrientos-Perez, M.
dc.date.accessioned2022-03-12T16:24:29Z
dc.date.accessioned2026-01-11T11:13:27Z
dc.date.available2022-03-12T16:24:29Z
dc.date.issued2019
dc.identifier.doidoiWOS:000485303800085
dc.identifier.eissn1432-0428
dc.identifier.issn0012-186X
dc.identifier.urihttps://hdl.handle.net/11424/226355
dc.identifier.wosWOS:000485303800085
dc.language.isoeng
dc.publisherSPRINGER
dc.relation.ispartofDIABETOLOGIA
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleEfficacy and safety of liraglutide vs placebo in children and adolescents with type 2 diabetes: the ellipse randomised trial results
dc.typeconferenceObject
dspace.entity.typePublication
oaire.citation.endPageS44
oaire.citation.startPageS44
oaire.citation.titleDIABETOLOGIA
oaire.citation.volume62

Files